University of California San Francisco
Give to UCSFParents of children under the age of five-years-old now have the option to vaccinate their infants and young children against COVID-19. Our expert looks at potential vaccine side effects, risks of COVID-19, access and vaccine effectiveness in children.
UCSF is welcoming its first patients to the Nancy Friend Pritzker Psychiatry Building, a one-of-a-kind treatment center that aims to redefine mental health services and make a bold statement against stigma.
A new study shows that when residents in Black communities have a stroke, they are at greater risk of receiving care at a less-resourced hospital, where their chances of recovery are slimmer.
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UCSF’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine.
A world-class team of researchers co-led by UCSF’s Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development.
For the seventh consecutive year, UCSF is co-sponsoring the Precision Medicine World Conference (PMWC) from June 28-30, 2022 to share the latest in this rapidly evolving space.
In a groundbreaking finding, a new study led by UCSF found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women.
Jack S. Resneck Jr., MD, was inaugurated today as the 177th president of the American Medical Association (AMA). Resneck is a dermatologist, professor and vice-chair of the Department of Dermatology at UCSF.
When Cheryl Broyles was diagnosed with glioblastoma, her goal was to outlive the disease’s 15-month prognosis. That was 22 years ago. Broyles’ survival has been the result of luck, tumor location, and cutting-edge treatment and diagnostics.
For many women, breast cancer screening with a three-dimensional imaging technique called digital breast tomosynthesis (DBT) may not offer advantages over digital mammography, but for some it may reduce the chance of an advanced cancer diagnosis, according to a new JAMA study.